STOCK TITAN

Integra (IART) director gets 17,700 RSUs; 882 shares withheld for taxes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Integra LifeSciences director Keith Bradley reported routine equity compensation and related tax withholding. He received 17,700 Restricted Stock Units (RSUs) on May 7, 2026 under Integra’s Fifth Amended and Restated 2003 Equity Incentive Plan, with each RSU representing a right to one share of common stock and vesting in full on the one-year anniversary of the grant date. To cover tax obligations, 882 shares of common stock were withheld at $13.92 per share. Following these transactions, Bradley directly holds 88,254 shares of Integra common stock.

Positive

  • None.

Negative

  • None.
Insider BRADLEY KEITH
Role null
Type Security Shares Price Value
Tax Withholding Common Stock 882 $13.92 $12K
Grant/Award Restricted Stock Units 17,700 $0.00 --
Holdings After Transaction: Common Stock — 88,254 shares (Direct, null); Restricted Stock Units — 17,700 shares (Direct, null)
Footnotes (1)
  1. Grant of restricted stock units (RSUs) pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of IART common stock. RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026.
RSU grant size 17,700 units Restricted Stock Units granted on May 7, 2026
Tax-withheld shares 882 shares Common stock delivered to satisfy tax liability at $13.92
Tax withholding price $13.92 per share Price for 882-share tax-withholding disposition
Post-transaction holdings 88,254 shares Common stock directly held after transactions
Underlying common stock 17,700 shares Common shares underlying new RSU award
Restricted Stock Units financial
"The filing reports 17,700 Restricted Stock Units as a grant."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax-withholding disposition financial
"The 882-share transaction is described as a tax-withholding disposition."
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
Equity Incentive Plan financial
"Grant of RSUs pursuant to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan."
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
grant/award acquisition financial
"The RSU transaction is coded as a grant/award acquisition."
contingent right to receive financial
"Each RSU represents a contingent right to receive one share of IART common stock."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BRADLEY KEITH

(Last)(First)(Middle)
1100 CAMPUS ROAD

(Street)
PRINCETON NEW JERSEY 08540

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
INTEGRA LIFESCIENCES HOLDINGS CORP [ IART ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/09/2026F882D$13.9288,254D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)05/07/2026A17,700 (2) (2)Common Stock17,700$017,700D
Explanation of Responses:
1. Grant of restricted stock units (RSUs) pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of IART common stock.
2. RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026.
Remarks:
/s/ Michael D. Hutchinson; Attorney-in-Fact for Keith Bradley05/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Integra LifeSciences (IART) director Keith Bradley report?

Keith Bradley reported a routine equity grant and related tax withholding. He received 17,700 Restricted Stock Units and had 882 common shares withheld to satisfy tax obligations, with no open-market purchases or sales disclosed in this filing.

How many Restricted Stock Units did Keith Bradley receive from Integra LifeSciences (IART)?

Keith Bradley received 17,700 Restricted Stock Units. The grant was made under Integra LifeSciences Holdings Corporation’s Fifth Amended and Restated 2003 Equity Incentive Plan and each RSU represents a contingent right to receive one share of IART common stock.

When do Keith Bradley’s new Integra LifeSciences (IART) RSUs vest?

The RSUs vest in full on the one-year anniversary of the May 7, 2026 grant date. This means the entire 17,700-unit award vests at once rather than gradually over multiple years, subject to the plan’s standard conditions.

Why were 882 Integra LifeSciences (IART) shares disposed of in this Form 4?

The 882-share disposition reflects a tax-withholding transaction, not an open-market sale. Shares were delivered at $13.92 per share to satisfy tax liabilities associated with equity compensation, a common administrative mechanism for insiders.

How many Integra LifeSciences (IART) shares does Keith Bradley hold after these transactions?

After the reported tax-withholding transaction, Keith Bradley directly holds 88,254 shares of Integra LifeSciences common stock. This figure reflects his post-transaction ownership as shown in the Form 4’s non-derivative holdings column.

Are Keith Bradley’s Integra LifeSciences (IART) transactions considered open-market buys or sells?

No open-market buys or sells are reported. The Form 4 shows a grant/award acquisition of 17,700 Restricted Stock Units and a tax-withholding disposition of 882 shares used to cover tax obligations related to equity compensation.